These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8717406)

  • 61. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
    Pascual DW; White MD; Larson T; Walters N
    J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
    Goodman MG
    Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
    Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
    Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction of T helper cells and cytokines for mucosal IgA responses.
    Xu-Amano J; Beagley KW; Mega J; Fujihashi K; Kiyono H; McGhee JR
    Adv Exp Med Biol; 1992; 327():107-17. PubMed ID: 1295331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
    Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura SS
    Vaccine; 2000 Jan; 18(14):1344-50. PubMed ID: 10618531
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
    Walia K; Vohra H; Singh H; Ganguly NK
    Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
    Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
    Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
    Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
    Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin.
    Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; McGhee JR
    Ann N Y Acad Sci; 1996 Oct; 795():361-5. PubMed ID: 8958955
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation.
    Kjerrulf M; Grdic D; Kopf M; Lycke N
    Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay.
    Mayer S; Laumer M; Mackensen A; Andreesen R; Krause SW
    Immunobiology; 2002 Jul; 205(3):282-9. PubMed ID: 12182454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Interleukin-4 (IL-4)].
    Nagai N; Kashiwamura S; Nakanishi K; Shinka S
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1099-108. PubMed ID: 8002629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Function of alpha beta TCR+ intestinal intraepithelial lymphocytes: Th1- and Th2-type cytokine production by CD4+CD8- and CD4+CD8+ T cells for helper activity.
    Fujihashi K; Yamamoto M; McGhee JR; Beagley KW; Kiyono H
    Int Immunol; 1993 Nov; 5(11):1473-81. PubMed ID: 8260458
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
    Toida N; Hajishengallis G; Wu HY; Russell MW
    Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cells and cytokines in mucosal immunity and inflammation.
    Beagley KW; Elson CO
    Gastroenterol Clin North Am; 1992 Jun; 21(2):347-66. PubMed ID: 1512047
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of IgA responses in cattle, humans and mice.
    Estes DM
    Vet Immunol Immunopathol; 2010 Dec; 138(4):312-7. PubMed ID: 21074276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
    Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
    Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.